Crestron Latin representa a Crestron Electronics en América Latina, Crestron ha liderado el camino en innovación tecnológica desde 1972. Ofrecemos soluciones de automatización que transforman la vida cotidiana, facilitando las tareas diarias y mejorando la eficiencia y productividad de nuestros clientes. Nos comprometemos a atender las necesidades específicas del mercado latinoamericano, brindando soluciones rápidas, escalables y personalizadas. Al elegir Crestron Latin, no solo accede a tecnología de vanguardia fabricada por Crestron Electronics; también cuenta con un equipo regional que ofrece soporte 24/7 y garantiza productos diseñados y manufacturados en Estados Unidos, adaptados para el éxito en nuestra región.
Confluence Trenchless Solutions
Trenchless Technology Manufacturer
Columbus Clinical Services, LLC
Columbus Clinical Services is a versatile medical facility that specializes in providing clinical site solutions tailored for pharmaceutical, biotech companies, medical device manufacturers, and contract research organizations (CROs) looking for optimal research sites to enroll patients in their clinical trials. This Phase I-IV clinical research facility is dedicated to helping companies expand their patient demographic diversity, reaching a broader patient base in a notably reduced timeframe.
Clinasyst
We are a Clinical Trial Management System company.
Claro Enterprise Solutions, LLC
At Claro Enterprise Solutions, we deliver outcome-driven Managed Services and AI-powered IT Solutions that help organizations thrive in a digitally complex world. Our industry tailored solutions seamlessly bridge digital and physical environments and deliver measurable business outcomes with clarity and simplicity.
CCPIT Construction Industry Sub-council
AlphaESS is a leading global energy storage solution and service provider. The company specializes in residential and commercial applications and delivers pre-eminent products and fit-for-purpose solutions. AlphaESS has 15+ subsidiaries providing local services and 90,000+ systems actively running in 90+ countries, enabling millions of people to enjoy reliable, accessible and clean energy. | .
CannaBIZ Collects
CannaBIZ Collects and the Cannabiz Credit Association (CCA) together form the leading credit and collections infrastructure for the cannabis industry—helping operators sell smarter, manage risk, and recover cash. CannaBIZ Collects is the nation’s first and largest cannabis-focused commercial collections agency. Since 2017, we’ve helped over 1,800 cannabis companies recover millions in past-due receivables across all legal U.S. markets. Our team specializes exclusively in cannabis debt, combining industry expertise with a professional, relationship-conscious approach to recovering funds. We operate on a contingency-only model, meaning there is no cost unless we successfully recover money. From soft collections and structured payment plans to legal escalation through our network of experienced cannabis attorneys, we act as the final line of defense for operators dealing with 90+ day unpaid invoices. Our goal is simple: turn outstanding receivables into cash while protecting valuable business relationships. The Cannabiz Credit Association (CCA) is the cannabis industry’s first credit bureau—built to help companies prevent bad debt before it happens. CCA aggregates real-time accounts receivable (A/R) and payment data from hundreds of cannabis operators, creating a shared data network that delivers actionable credit insights. With over $2.6B+ in reported A/R and payment behavior, CCA provides tools such as credit reports, risk scores, portfolio monitoring, and license-level entity matching—giving operators a complete view of who they’re selling to. Our platform empowers finance and sales teams to make informed decisions, set appropriate credit limits, and prioritize the right customers. Together, CannaBIZ Collects and CCA provide a full lifecycle solution: • Before the sale: Use CCA to evaluate customer creditworthiness and avoid risky accounts • During the relationship: Monitor payment behavior and identify early warning signs • After delinquency: Leverage CannaBIZ Collects to recover outstanding balances In an industry where access to reliable credit data has historically been limited, our mission is to bring transparency, accountability, and financial discipline to cannabis trade credit. Sell with confidence. Get paid. Repeat.
BUZZPARK
We are a manufacturer of balls for ball pit and various ball products. | We manufacture balls for ballpits, ball chairs etc. and zipties.
Biobeat
Biobeat is redefining hypertension diagnosis and management with a first-of-its-kind, FDA-cleared, cuffless 24-hour blood pressure monitoring platform that delivers accurate, reliable, and comfortable monitoring without disrupting daily life. Our mission is to ensure that all patients are effectively monitored and managed. By combining 24-hour blood pressure data from our wireless, non-invasive chest patch with patient-reported insights, Biobeat provides a complete view of the patient journey. Clinicians can identify trends, correlate symptoms with vital signs, and make confident, personalized treatment decisions, eliminating the discomfort of traditional cuffs and replacing fragmented data with a clear, actionable picture of overall patient health. | Biobeat is redefining the way hypertension is diagnosed and managed through a first-of-its-kind, FDA-cleared, cuffless 24-hour blood pressure monitoring platform that delivers accurate, reliable, and comfortable monitoring without disrupting daily life. Our mission is to ensure that all patients are effectively monitored and managed. By combining 24-hour blood pressure data from our wireless, non-invasive chest patch with patient-reported insights, Biobeat provides a complete view of the patient journey. Clinicians can identify trends, correlate symptoms with vital signs, and make confident, personalized treatment decisions. Biobeat’s clinically validated platform is setting a new standard in hypertension care, eliminating the discomfort of traditional cuff-based monitoring, reducing white coat syndrome, and replacing fragmented data with a clear, actionable picture of patient health.